Health Care · Biotechnology
Hemab: Risk & public record
Hemab: 6 research papers in five years.
Data updated Nov 20, 2026 · Back to the company report
What the registers and the postings say about this employer.
Legal entity active
Hemab ApS
Not checked
Sanctions lists
OFAC SDN, EU consolidated · sanctionssearch.ofac.treas.gov ↗
No match
Phishing reports
OpenPhish, Phishing.Database · openphish.com ↗
None
Layoff notices
US WARN notices on file · dol.gov ↗
None
Full employer checkScam signs in adverts, mail records, visa registers, domain history
Sources: company registers, the Alion truth index, OFAC and EU sanctions lists, US WARN notices
Public record
Hemab: 6 research papers in five years.
Research outputpapers its people wrote, per OpenAlex
6papers in five years
60citations
Platelet Disorders and Treatments
Medicine
9 papers
Hemophilia Treatment and Research
Medicine
9 papers
Blood Coagulation and Thrombosis Mechanisms
Medicine
6 papers
Antiplatelet Therapy and Cardiovascular Diseases
Medicine
3 papers
Complement system in diseases
Immunology and Microbiology
2 papers
Each line links its register: the agency's page, the EU Transparency Register, the FEC, the USPTO, CourtListener.
